Evaluation of the Effectiveness of Pharmacists in Implementing the SCRIPT Protocol
| Status: | Recruiting |
|---|---|
| Conditions: | Women's Studies |
| Therapuetic Areas: | Reproductive |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | January 2015 |
| End Date: | January 2017 |
| Contact: | Jennifer Taylor, PharmD |
| Email: | Jennifer.Taylor4@providence.org |
| Phone: | 509-474-2228 |
Evaluation of the Effectiveness of Pharmacists in Implementing the Smoking Cessation and Reduction in Pregnancy and Treatment (SCRIPT) Protocol
There is a significant need for nicotine cessation programs for pregnant women in Spokane
County. SCRIPT has been proven to be an effective method for smoking cessation in pregnant
women. This study will evaluate the success of SCRIPT delivered by pharmacists. At the end
of the study, the investigators hope to have three questions answered: 1) what is the quit
rate of pregnant women in the Spokane area who receive the SCRIPT intervention delivered by
pharmacists? 2) How does the quit rate compare to the quit rates of SCRIPT programs
delivered by other health care providers as documented in the literature? And 3) Does the
SCRIPT intervention have a significant effect on quit rates for pregnant women compared to
current Spokane county quit rates? Urine cotinine tests will be used to document smoking
status before delivery of the SCRIPT program, approximately one week after quit date and at
>36 wks gestation or at delivery for study participants.
County. SCRIPT has been proven to be an effective method for smoking cessation in pregnant
women. This study will evaluate the success of SCRIPT delivered by pharmacists. At the end
of the study, the investigators hope to have three questions answered: 1) what is the quit
rate of pregnant women in the Spokane area who receive the SCRIPT intervention delivered by
pharmacists? 2) How does the quit rate compare to the quit rates of SCRIPT programs
delivered by other health care providers as documented in the literature? And 3) Does the
SCRIPT intervention have a significant effect on quit rates for pregnant women compared to
current Spokane county quit rates? Urine cotinine tests will be used to document smoking
status before delivery of the SCRIPT program, approximately one week after quit date and at
>36 wks gestation or at delivery for study participants.
1. The goal of this project is to evaluate the success of pharmacists in delivering the
SCRIPT smoking cessation program. The research questions that need to be addressed are: i.
What is the quit rate of pregnant women in the Spokane area who receive the SCRIPT
intervention delivered by a pharmacist? ii. How does this quit rate compare to the quit
rates of other SCRIPT programs given by other health care providers (social workers, nurses,
etc.)? iii. Does the SCRIPT intervention have a significant effect on quit rates for smoking
pregnant women compared to current Spokane county quit rates?
SCRIPT smoking cessation program. The research questions that need to be addressed are: i.
What is the quit rate of pregnant women in the Spokane area who receive the SCRIPT
intervention delivered by a pharmacist? ii. How does this quit rate compare to the quit
rates of other SCRIPT programs given by other health care providers (social workers, nurses,
etc.)? iii. Does the SCRIPT intervention have a significant effect on quit rates for smoking
pregnant women compared to current Spokane county quit rates?
Inclusion Criteria:
- Pregnant
- nicotine use
- English speaking
- 18 years of age or older
Exclusion Criteria:
- Males due to pregnancy status not applicable
We found this trial at
1
site
Spokane, Washington 99207
Phone: 509-482-3057
Click here to add this to my saved trials
